Latest news for VerifyMe (NASDAQ:VRMEW) Stock

VerifyMe Inc together with its subsidiaries, is a traceability and customer support services provider using specialized software and process technology. The company operates a Precision Logistics Segment and an Authentication Segment to provide specialized logistics for time-and-temperature sensitive products, as well as item-level traceability, anti-diversion and anti-counterfeit protection, brand protection and enhancement technology solutions. It Generates the majority of its revenue from the Precision Logistics Segment. Through its Precision Logistics segment, it provides a value-added service for sensitive parcel management driven by a proprietary software platform that provides predictive analytics from key metrics such as pre-shipment weather analysis, flight-tracking, and Others.

VerifyMe Inc

WIIM

SWKS

Skyworks shares are trading lower after the company issued Q2 adjusted EPS guidance below estimates.

News

Guidance

McKesson Sees FY25 Adj. EPS $32.55-$32.95 Vs $36.70 Estimate

<p><strong>Rexford Industrial Realty</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/REXR#NYSE">REXR</a>) reported its Q4 earnings results on Wednesday, February 5, 2025 at 04:08 PM.</p>
<p>Here's what investors need to know about the announcement.</p>
<h3>Earnings</h3>
<p>Rexford Industrial Realty missed estimated earnings by 0.0%, reporting an EPS of $0.58 versus an estimate of $0.58.</p>
<p>Revenue was up $31.83 million from the same period last year.</p>
<h3>Previous Earnings Records</h3>
<p>Last quarter the company beat on EPS by $0.01 which was followed by a 9.0% drop in the share price the next day.</p>
<p>Here's a look at Rexford Industrial Realty's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.58</td>
<td>0.58</td>
<td>0.57</td>
<td></td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.59</td>
<td>0.60</td>
<td>0.58</td>
<td>0.56</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>239.70M</td>
<td>227.67M</td>
<td>211.56M</td>
<td>201.88M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>238.40M</td>
<td>232.97M</td>
<td>210.99M</td>
<td>207.91M</td>
</tr>
</tbody>
</table>
</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Guidance</h3>
<p>Rexford Industrial Realty management provided guidance for FY 2025, expecting earnings between $2.37 and $2.41 per share.</p>
<p>To track all earnings releases for Rexford Industrial Realty <a href="https://www.benzinga.com/quote/REXR/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Earnings

REXR

Insights into Rexford Industrial Realty Q4 Earnings

<p><strong>CSG Systems Intl</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSGS#NASDAQ">CSGS</a>) announced its Q4 earnings on Wednesday, February 5, 2025 at 04:00 PM.</p>
<p>Here's a breakdown of the earnings report.</p>
<h3>Earnings</h3>
<p>CSG Systems Intl beat estimated earnings by 36.0%, reporting an EPS of $1.65 versus an estimate of $1.21.</p>
<p>Revenue was up $19.33 million from the same period last year.</p>
<h3>Previous Earnings Records</h3>
<p>During the previous quarter, the company missed on EPS by $0.0, leading to a 9.0% increase share price change the next day.</p>
<p>Here's a look at CSG Systems Intl's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>1.06</td>
<td>0.91</td>
<td>0.93</td>
<td>0.86</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.06</td>
<td>1.02</td>
<td>1.01</td>
<td>0.92</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>296.24M</td>
<td>273.76M</td>
<td>284.17M</td>
<td>281.16M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>295.14M</td>
<td>290.32M</td>
<td>295.13M</td>
<td>297.32M</td>
</tr>
</tbody>
</table>
</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Guidance</h3>
<p>CSG Systems Intl management provided guidance for FY 2025, expecting earnings between $4.55 and $4.8 per share.</p>
<p>To track all earnings releases for CSG Systems Intl <a href="https://www.benzinga.com/quote/CSGS/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


CSGS

CSG Systems Intl Earnings Report: Q4 Overview

<p><strong>Amtech Systems</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASYS#NASDAQ">ASYS</a>) reported its Q1 earnings results on Wednesday, February 5, 2025 at 04:05 PM.</p>
<p>Here's what investors need to know about the announcement.</p>
<h3>Earnings</h3>
<p>Amtech Systems beat estimated earnings by 0.06%, reporting an EPS of $0.06 versus an estimate of $0.0.</p>
<p>Revenue was down $535 thousand from the same period last year.</p>
<h3>Earnings History Overview</h3>
<p>In the previous quarter, the company missed on EPS by $0.01, resulting in a 8.0% drop change in the share price the following day.</p>
<p>Here's a look at Amtech Systems's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.01</td>
<td>-0.06</td>
<td>-0.13</td>
<td>-0.26</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0</td>
<td>0.08</td>
<td>-0.01</td>
<td>-0.04</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>23.75M</td>
<td>24.15M</td>
<td>23.50M</td>
<td>22.25M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>24.11M</td>
<td>26.75M</td>
<td>25.43M</td>
<td>24.92M</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for Amtech Systems <a href="https://www.benzinga.com/quote/ASYS/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


ASYS

Amtech Systems Q1 Earnings Summary & Key Takeaways

<p>The Q4 earnings report for <strong>Corpay</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPAY#NYSE">CPAY</a>) was released on Wednesday, February 5, 2025 at 04:05 PM.</p>
<p>Here's what investors need to know about the latest announcement.</p>
<h3>Earnings</h3>
<p>Corpay beat estimated earnings by 0.0%, reporting an EPS of $5.36 versus an estimate of $5.35.</p>
<p>Revenue was up $96.68 million from the same period last year.</p>
<h3>Previous Earnings Records</h3>
<p>The company beat on EPS by $0.03 in the last quarter, resulting in a 6.0% increase share price change the following day.</p>
<p>Here's a look at Corpay's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>4.97</td>
<td>4.50</td>
<td>4.1</td>
<td>4.48</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>5</td>
<td>4.55</td>
<td>4.1</td>
<td>4.44</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>1.03B</td>
<td>972.73M</td>
<td>938.02M</td>
<td>970.15M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>1.03B</td>
<td>975.71M</td>
<td>935.25M</td>
<td>937.32M</td>
</tr>
</tbody>
</table>
</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Guidance</h3>
<p>Corpay management provided guidance for Q1 2025, expecting earnings between $4.45 and $4.55 per share.</p>
<p>To track all earnings releases for Corpay <a href="https://www.benzinga.com/quote/CPAY/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


CPAY

Corpay: Q4 Earnings Insights

<p><strong>Blue Bird</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLBD#NASDAQ">BLBD</a>) just disclosed its Q1 earnings on Wednesday, February 5, 2025 at 04:00 PM.</p>
<p>Here's a brief overview of the earnings report.</p>
<h3>Earnings</h3>
<p>Blue Bird beat estimated earnings by 14.000000000000002%, reporting an EPS of $0.92 versus an estimate of $0.81.</p>
<p>Revenue was down $3.79 million from the same period last year.</p>
<h3>Overview of Past Earnings</h3>
<p>The company missed on EPS by $0.15 in the last quarter, resulting in a 5.0% drop share price change the following day.</p>
<p>Here's a look at Blue Bird's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.92</td>
<td>0.51</td>
<td>0.48</td>
<td>0.37</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.77</td>
<td>0.91</td>
<td>0.89</td>
<td>0.91</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>346.59M</td>
<td>328.60M</td>
<td>298.41M</td>
<td>275.13M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>350.21M</td>
<td>333.37M</td>
<td>345.92M</td>
<td>317.66M</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for Blue Bird <a href="https://www.benzinga.com/quote/BLBD/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


BLBD

Blue Bird: Q1 Earnings Insights

Management

INSG

Inseego Appoints Jeff Tuder As Chairman; Succeeds Phil Brace

<p><strong>Conmed</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNMD#NYSE">CNMD</a>) just disclosed its Q4 earnings on Wednesday, February 5, 2025 at 04:05 PM.</p>
<p>Here's a brief overview of the earnings report.</p>
<h3>Earnings</h3>
<p>Conmed beat estimated earnings by 12.0%, reporting an EPS of $1.34 versus an estimate of $1.2.</p>
<p>Revenue was up $18.90 million from the same period last year.</p>
<h3>Analysis of Past Earnings</h3>
<p>The company beat on EPS by $0.06 in the last quarter, resulting in a 5.0% increase share price change the following day.</p>
<p>Here's a look at Conmed's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.99</td>
<td>0.91</td>
<td>0.74</td>
<td>1.11</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.05</td>
<td>0.98</td>
<td>0.79</td>
<td>1.06</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>318.13M</td>
<td>332.32M</td>
<td>306.78M</td>
<td>332.20M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>316.70M</td>
<td>332.10M</td>
<td>312.27M</td>
<td>327.05M</td>
</tr>
</tbody>
</table>
</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Guidance</h3>
<p>Conmed management provided guidance for FY 2025, expecting earnings between $4.25 and $4.4 per share.</p>
<p>To track all earnings releases for Conmed <a href="https://www.benzinga.com/quote/CNMD/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


CNMD

Conmed Q4 Earnings Summary & Key Takeaways

<p>Itau Unibanco Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ITUB#NYSE">ITUB</a>) reported quarterly earnings of $0.19 per share which met the analyst consensus estimate. This is unchanged from the same period last year.  The company reported quarterly sales of $7.56 billion which missed the analyst consensus estimate of $7.61 billion by 0.57 percent.  This is a 8.58 percent decrease over sales of $8.27 billion the same period last year.</p>


Earnings Misses

ITUB

Itau Unibanco Holding Q4 2024 GAAP EPS $0.19, Inline, Sales $7.56B Miss $7.61B Estimate

<p><strong>Qiagen</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QGEN#NYSE">QGEN</a>) reported its Q4 earnings results on Wednesday, February 5, 2025 at 04:05 PM.</p>
<p>Here's what investors need to know about the announcement.</p>
<h3>Earnings</h3>
<p>Qiagen missed estimated earnings by -2.0%, reporting an EPS of $0.61 versus an estimate of $0.62.</p>
<p>Revenue was up $11.84 million from the same period last year.</p>
<h3>Analysis of Past Earnings</h3>
<p>Last quarter the company beat on EPS by $0.03 which was followed by a 1.0% increase in the share price the next day.</p>
<p>Here's a look at Qiagen's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.54</td>
<td>0.51</td>
<td>0.44</td>
<td>0.53</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.57</td>
<td>0.55</td>
<td>0.46</td>
<td>0.55</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>491.75M</td>
<td>494.49M</td>
<td>457.33M</td>
<td>501.28M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>502.00M</td>
<td>496.00M</td>
<td>458.80M</td>
<td>509.16M</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for Qiagen <a href="https://www.benzinga.com/quote/QGEN/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


QGEN

Qiagen Q4 Earnings Report: What Investors Need to Know

<p>The earnings results for <strong>Omega Healthcare Invts</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OHI#NYSE">OHI</a>) for Q4 were made public on Wednesday, February 5, 2025 at 04:15 PM.</p>
<p>Here's a comprehensive overview of the announcement.</p>
<h3>Earnings</h3>
<p>Omega Healthcare Invts beat estimated earnings by 1.0%, reporting an EPS of $0.74 versus an estimate of $0.73.</p>
<p>Revenue was up $40.00 million from the same period last year.</p>
<h3>Past Earnings Performance</h3>
<p>In the previous quarter, the company beat on EPS by $0.03, resulting in a 0.0% increase change in the share price the following day.</p>
<p>Here's a look at Omega Healthcare Invts's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.71</td>
<td>0.68</td>
<td>0.65</td>
<td></td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.74</td>
<td>0.71</td>
<td>0.68</td>
<td>0.68</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>261.64M</td>
<td>246.73M</td>
<td>231.64M</td>
<td>233.82M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>276.03M</td>
<td>252.75M</td>
<td>243.30M</td>
<td>239.32M</td>
</tr>
</tbody>
</table>
</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Guidance</h3>
<p>Omega Healthcare Invts management provided guidance for FY 2025, expecting earnings between $2.9 and $2.98 per share.</p>
<p>To track all earnings releases for Omega Healthcare Invts <a href="https://www.benzinga.com/quote/OHI/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Omega Healthcare Invts Q4 Earnings Assessment

CTVA

Corteva shares are trading lower after the company reported worse-than-expected Q4 sales results.

<p>The Q3 earnings report for <strong>ePlus</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLUS#NASDAQ">PLUS</a>) was released on Wednesday, February 5, 2025 at 04:05 PM.</p>
<p>Here's what investors need to know about the latest announcement.</p>
<h3>Earnings</h3>
<p>ePlus missed estimated earnings by -13.0%, reporting an EPS of $1.06 versus an estimate of $1.22.</p>
<p>Revenue was up $1.91 million from the same period last year.</p>
<h3>Overview of Past Earnings</h3>
<p>The company missed on EPS by $0.03 in the previous quarter, leading to a 16.0% drop share price change the next day.</p>
<p>Here's a look at ePlus's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q2 2025</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>1.39</td>
<td>1.17</td>
<td>1.17</td>
<td>1.38</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.36</td>
<td>1.13</td>
<td>0.93</td>
<td>1.18</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>576.50M</td>
<td>555.23M</td>
<td>537.83M</td>
<td>595.07M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>515.17M</td>
<td>544.54M</td>
<td>554.46M</td>
<td>509.06M</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for ePlus <a href="https://www.benzinga.com/quote/PLUS/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


PLUS

ePlus Earnings Report: Q3 Overview

<p>The earnings results for <strong>Equitable Hldgs</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EQH#NYSE">EQH</a>) for Q4 were made public on Wednesday, February 5, 2025 at 04:15 PM.</p>
<p>Here's a comprehensive overview of the announcement.</p>
<h3>Earnings</h3>
<p>Equitable Hldgs missed estimated earnings by -3.0%, reporting an EPS of $1.57 versus an estimate of $1.62.</p>
<p>Revenue was up $1.45 billion from the same period last year.</p>
<h3>Past Earnings Performance</h3>
<p>During the previous quarter, the company missed on EPS by $0.0, leading to a 1.0% drop share price change the next day.</p>
<p>Here's a look at Equitable Hldgs's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>1.53</td>
<td>1.40</td>
<td>1.33</td>
<td>1.20</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.53</td>
<td>1.43</td>
<td>1.43</td>
<td>1.33</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>3.86B</td>
<td>3.81B</td>
<td>3.72B</td>
<td>3.54B</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>3.08B</td>
<td>3.51B</td>
<td>2.23B</td>
<td>2.17B</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for Equitable Hldgs <a href="https://www.benzinga.com/quote/EQH/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Equitable Hldgs Q4 Earnings Assessment

<p>The earnings results for <strong>Black Hills</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BKH#NYSE">BKH</a>) for Q4 were made public on Wednesday, February 5, 2025 at 04:15 PM.</p>
<p>Here's a comprehensive overview of the announcement.</p>
<h3>Earnings</h3>
<p>Black Hills beat estimated earnings by 2.0%, reporting an EPS of $1.37 versus an estimate of $1.34.</p>
<p>Revenue was up $5.40 million from the same period last year.</p>
<h3>Earnings History Overview</h3>
<p>The company missed on EPS by $0.17 in the last quarter, resulting in a 1.0% drop share price change the following day.</p>
<p>Here's a look at Black Hills's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.52</td>
<td>0.25</td>
<td>1.70</td>
<td>1.08</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.35</td>
<td>0.33</td>
<td>1.87</td>
<td>1.17</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>446.19M</td>
<td>510.60M</td>
<td>683.04M</td>
<td>863.66M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>401.60M</td>
<td>402.60M</td>
<td>726.40M</td>
<td>591.70M</td>
</tr>
</tbody>
</table>
</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Guidance</h3>
<p>Black Hills management provided guidance for FY 2025, expecting earnings between $4.0 and $4.2 per share.</p>
<p>To track all earnings releases for Black Hills <a href="https://www.benzinga.com/quote/BKH/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Black Hills Earnings Review: Q4 Summary

<p>The Q4 earnings report for <strong>UDR</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UDR#NYSE">UDR</a>) was released on Wednesday, February 5, 2025 at 04:16 PM.</p>
<p>Here's what investors need to know about the latest announcement.</p>
<h3>Earnings</h3>
<p>UDR missed estimated earnings by 0.0%, reporting an EPS of $0.63 versus an estimate of $0.63.</p>
<p>Revenue was up $9.55 million from the same period last year.</p>
<h3>Performance in Previous Earnings</h3>
<p>In the previous quarter, the company missed on EPS by $0.0, resulting in a 3.0% drop change in the share price the following day.</p>
<p>Here's a look at UDR's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.62</td>
<td>0.61</td>
<td>0.61</td>
<td></td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.62</td>
<td>0.62</td>
<td>0.61</td>
<td>0.54</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>416.51M</td>
<td>414.11M</td>
<td>408.61M</td>
<td>410.19M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>418.09M</td>
<td>413.33M</td>
<td>411.67M</td>
<td>410.89M</td>
</tr>
</tbody>
</table>
</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Guidance</h3>
<p>UDR management provided guidance for FY 2025, expecting earnings between $2.45 and $2.55 per share.</p>
<p>To track all earnings releases for UDR <a href="https://www.benzinga.com/quote/UDR/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


UDR Earnings Review: Q4 Summary

<p><strong>Lesaka Technologies</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSAK#NASDAQ">LSAK</a>) just disclosed its Q2 earnings on Wednesday, February 5, 2025 at 04:05 PM.</p>
<p>Here's a brief overview of the earnings report.</p>
<h3>Earnings</h3>
<p>Lesaka Technologies missed estimated earnings by 0.0%, reporting an EPS of $0.01 versus an estimate of $0.01.</p>
<p>Revenue was up $2.92 million from the same period last year.</p>
<h3>Earnings History Overview</h3>
<p>In the previous quarter, the company beat on EPS by $0.08, resulting in a 3.0% drop change in the share price the following day.</p>
<p>Here's a look at Lesaka Technologies's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>-0.04</td>
<td>-0.06</td>
<td>-0.04</td>
<td>-0.03</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.04</td>
<td>0.02</td>
<td>0.02</td>
<td>0.01</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>144.16M</td>
<td>149.30M</td>
<td>145.53M</td>
<td>144.47M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>145.55M</td>
<td>146.05M</td>
<td>138.19M</td>
<td>143.89M</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for Lesaka Technologies <a href="https://www.benzinga.com/quote/LSAK/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


LSAK

Lesaka Technologies Q2 Earnings Assessment

Earnings Beats

Becton, Dickinson Q1 2025 Adj. EPS $3.43 Beats $2.98 Estimate, Sales $5.168B Beat $5.100B Estimate

<p>Horace Mann Educators (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HMN#NYSE">HMN</a>) reported quarterly earnings of $1.62 per share which beat the analyst consensus estimate of $1.02 by 58.82 percent. This is a 92.86 percent increase over earnings of $0.84 per share from the same period last year.  The company reported quarterly sales of $409.00 million which missed the analyst consensus estimate of $418.33 million by 2.23 percent.  This is a 1.51 percent increase over sales of $402.90 million the same period last year.</p>


Horace Mann Educators Q4 Adj $1.62 Beats $1.02 Estimate, Sales $409.00M Miss $418.33M Estimate

VerifyMe

VerifyMe, Inc. (NASDAQ:<a class="ticker" href="/stock/VRME#NASDAQ">VRME</a>)(NASDAQ:<a class="ticker" href="/stock/VRMEW#NASDAQ">VRMEW</a>) announced the pricing of its underwritten public offering of 2,173,913 units at a price to the public of $4.60 per unit. Each unit issued in the offering consists of one share of common stock and one warrant to purchase one share of common stock at an exercise price of $4.60. The common stock and warrants are immediately separable, will be issued separately, and are expected to begin trading on the Nasdaq Capital Market on June 18, 2020, under the symbols "VRME" and "VRMEW," respectively. VerifyMe expects to receive gross proceeds of $10.0 million, before deducting underwriting discounts and commissions and other estimated offering expenses. Concurrent with the offering, the Company will effectuate a reverse split of its issued and outstanding common stock and treasury stock at a ratio of 50-to-1. The reverse stock split is expected to be effective at 12:01 a.m., Eastern time, on Thursday, June 18, 2020. The share numbers and pricing information in this release are adjusted to reflect the impact of the reverse stock split.

VerifyMe has granted the underwriters a 45-day option to purchase up to 326,087 additional shares of common stock, or additional warrants to purchase 326,087 shares of common stock, or any combination thereof, at the public offering price to cover over-allotments, if any. The offering is expected to close on June 22, 2020, subject to customary closing conditions.

Maxim Group LLC is acting as lead book-running manager for the offering and Joseph Gunnar & Co., LLC is acting as co-book-running manager for the offering. 

Comments

VerifyMe

News

Latest news for VerifyMe (NASDAQ:VRMEW) Stock

Thursday, June 18, 2020

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga